Skip to Main Content

Why aren’t pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter in Professor Feuerstein’s class? And why is there no Kelley Blue Book for the price tag of a medicine?

We take on all of this and more in this week’s episode of “The Readout LOUD,” STAT’s newish biotech podcast. And by “we,” we mean Adam and Rebecca, because Damian ditched us for vacation.

Join us for a conversation about young billionaires (Mark Zuckerberg and John Arnold), how to find out how much a medicine costs (you might have to pick up the phone), and which large-cap biotechs earned an A or A+ this quarter (nobody!). And STAT’s Erin Mershon calls in from Washington to explain what it was like to grill members of Congress on why they aren’t grilling pharma executives.


If listening to us talk isn’t enough for you, here’s Rebecca’s story about the billionaire couple bankrolling the drug pricing debate. And here’s Erin’s story about the conspicuous absence of pharma execs on the hot seat on Capitol Hill.

And if you miss Damian as much as we do, we’ll all be back next Thursday evening — and every Thursday evening after that — so make sure to subscribe on iTunesStitcherGoogle Play, or wherever you get your podcasts.


Finally, don’t hesitate to email [email protected] with ideas about what we should cover, names of guests we should talk to, and complaints about our bad jokes.